Contributors


Vincent T. DeVita

Latest:

Pioneering Oncologist Provides an Overview of Advances in Cancer

Dr. Maurie Markman sits down with Dr. Vincent T. DeVita, one of the most influential researchers and physicians in the cancer care arena.



Dr. Daniel Petrylak

Latest:

Third-Line Jevtana Improves Progression-Free Survival in Prostate Cancer Subtype

"Sequential treatment in prostate cancer is really something that’s evolving over time," Dr. Daniel Petrylak said of the study findings presented at the European Society of Medical Oncology Congress 2019.


LAURIE TOICH

Latest:

Gut Reaction

Immunotherapy’s effectiveness may depend on the bacteria living in patients’ gastrointestinal tracts, studies show.


Sara M. Tolaney, MD, MPH

Latest:

Collaborating With Your Oncology Care Team to Manage Side Effects of HER2-Positive Metastatic Breast Cancer Treatment

Patients with metastatic breast cancer receiving HER2-targeted therapies should promptly report any respiratory symptoms or signs of lung and heart disease to their oncology care team to facilitate early intervention and management of side effects.


Noble Sprayberry

Latest:

New Surgical Techniques Are Cutting Edge

New surgical techniques can limit the risk of postoperative complications in patients with cancer.




Cindy Chmielewski

Latest:

Staying Within the Lines: Advice on Adhering to Myeloma Treatment

There are many reasons patients don’t take their drugs for myeloma and other cancers as prescribed, but there are ways to offer support.


Roberta Carson

Latest:

Five Tips for Easier Cancer Medication Management

Medication management can easily become overwhelming, but Roberta Carson offers advice to make sure medicine is given as prescribed.


Luis A. Diaz, M.D.

Latest:

Examining Response Rates in MSI-H and NTRK Fusion GI Cancers

Luis A. Diaz, M.D., head of the division of Solid Tumors at Memorial Sloan Kettering Cancer Center, discusses response rates in patients with microsatellite instability-high (MSI-H) or NTRK fusion gastrointestinal (GI) cancers.


Christin L. Melton, E.L.S.

Latest:

Global Perspectives on Hepatocellular Carcinoma

A panel of international oncology experts recently met to exchange thoughts on developments in the field of hepatocellular carcinoma (HCC), the most common form of liver cancer. They discussed screening and staging issues, treatment of advanced HCC and results of recent clinical trials.


Neal D. Shore, MD, FACS

Latest:

Dr. Shore Provides an Overview of Biomarkers in Prostate Cancer

Neal D. Shore, MD, FACS, medical director, Carolina Urologic Research Center, provides an overview of biomarkers in prostate cancer.


Tiffany Stump, RN BSN CBCN

Latest:

Putting Patients First

Tiffany Stump, RN BSN CBCN, of The Ohio State Wexner Medical Center at The James Cancer Hospital, Stefanie Spielman Comprehensive Breast Center, shares her Extraordinary Healer essay nomination of Sara Wolfe, B.S.N., RN, CBCN.


Gary Rodin, M.D.

Latest:

Facing Advanced Cancer's Struggles With CALM

Gary Rodin, M.D., head of the Department of Supportive Care at Princess Margaret Cancer Centre, in Toronto, Canada, discusses CALM, an intervention designed to help patients with advanced-stage cancer cope and talk about their concerns.


Jason Broderick

Latest:

Tecentriq Regimen Misses End Goal in Triple-Negative Breast Cancer

Tecentriq plus chemotherapy did not improve event-free survival in triple-negative breast cancer but increased rate of complete tumor removal.


Donna Clark, RN, BSN, OCN

Latest:

A Loyal Friendship Conquers Cancer's Boundaries

An Extraordinary Healer essay honoring Wanda Greeley, RN, OCN [ Sacred Heart Cancer Center in Pensacola Florida ]


Ann Tallman

Latest:

The Gift of Giving

It's not every day that one receives a cancer diagnosis.


Susan Meyers

Latest:

Cancer for the Long Haul

Suvivors with chronic disease can face ongoing challenges.


Christin Melton, ELST

Latest:

Working at the Speed of Light in Melanoma Advancements

Growing scientific insights have led to the swift development of treatments for advanced melanoma, leaving doctors to iron out details about their application.


The CURE Team

Latest:

Taking Control of Multiple Myeloma

Donna and Dr Gasparetto close the discussion by highlighting the importance of physicians utilizing their patients, as well as patients being involved with their multiple myeloma treatment.


Kerri Kaplan, executive director

Latest:

A Promising New Treatment Offers Hope in the Fight Against Pancreatic Cancer

Exciting new treatment options for patients with pancreatic cancer are on the rise, thanks to organizations such as the Lustgarten Foundation.


Karen Patterson

Latest:

Fighting Breathlessness

A recent and rare look at long-term lung cancer survivors shows breathlessness among them is persistent and common.


Candice Roth, M.S.N., RN

Latest:

A Leader in Every Sense

This essay written by registered nurse Candice Roth of Atrium Health’s Levine Cancer Institute, nominates her colleague and fellow registered nurse, Brenda Crump, for CURE®’s 2019 Extraordinary Healer® Award.


Maria Falzone

Latest:

The Biggest Cosmic Joke: Keeping Your Sense of Humor During Cancer

Despite being diagnosed with cholangiocarcinoma, a cancer of the bile duct, Maria Falzone, a safe sex speaker and comedienne, maintains her sense of humor.


Laurie Hatch

Latest:

An Expert Offers Advice on How to Incorporate Exercise Into Your Daily Routine

In an interview with CURE, Lutheran Medical Center oncology patient navigator Laurie Hatch explains the best ways for patients with cancer and survivors to restart their exercise routine and the best ways to get moving again and combat side effects from treatment like fatigue.


The Moving Mountains Team

Latest:

Moving Mountains for Multiple Myeloma: The Documentary

This is our full documentary from the 2016 climb of Mount Kilimanjaro.


Richard C. Frank

Latest:

My Patient, My Friend

A strong bond makes all the difference to an oncologist.


Laura Panjwani

Latest:

Combination Shows Early Promise in Melanoma

Tasigna and Mekinist is showing promise for the treatment of patients with BRAF/NRAS wild-type melanoma, according to a recent study.


Tamara Rodriguez

Latest:

Taking the Bad With the Good

For one mom, cancer presented an opportunity to teach her daughters empathy.